Document Detail


Cortical glucose metabolism in Huntington's disease.
MedLine Citation:
PMID:  1531155     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We measured cortical glucose metabolism with positron emission tomography in 39 patients with Huntington's disease (HD) and in 34 controls. In the 23 patients with symptoms for less than 5 years, there was a 15% decrease in metabolism in frontal and inferior parietal cortex. In 16 patients with symptoms for more than 5 years, all cortical areas (except temporal) were significantly involved, with metabolic rates 25 to 30% below those of controls. These data indicate the presence of a diffuse abnormality of cortical function with early involvement of frontal lobes in HD, suggesting that the clinical manifestations may not be related solely to basal ganglia pathology, even in early disease.
Authors:
W R Martin; C Clark; W Ammann; A J Stoessl; W Shtybel; M R Hayden
Related Documents :
19121775 - Salivary phosphorus and phosphate content of beverages: implications for the treatment ...
142925 - Detection of presymptomatic carriers of huntington's chorea.
8534685 - Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared with capd.
11728975 - Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of...
23893035 - The clinical profile of kawasaki disease of children from three polish centers: a retro...
17184515 - Successful pulmonary administration of activated recombinant factor vii in diffuse alve...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurology     Volume:  42     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1992 Jan 
Date Detail:
Created Date:  1992-03-02     Completed Date:  1992-03-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  223-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine (Neurology), University of Alberta, Edmonton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cerebral Cortex / metabolism*,  radionuclide imaging
Deoxyglucose / analogs & derivatives
Female
Fluorodeoxyglucose F18
Glucose / metabolism*
Humans
Huntington Disease / metabolism*,  radionuclide imaging
Male
Middle Aged
Tissue Distribution
Tomography, Emission-Computed*
Chemical
Reg. No./Substance:
154-17-6/Deoxyglucose; 50-99-7/Glucose; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vancomycin and teicoplanin: something old, something new.
Next Document:  Neuroactive kynurenines in Lyme borreliosis.